Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Morgenstern

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
Blood|January 29, 2000
Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapseK Tobal, J Newton, M Macheta, et al.
British Journal of Haematology|May 1, 1993
Bone marrow transplantation for acute myeloblastic leukaemia: an EBMT Leukaemia Working Party prospective analysis from HLA-typingP Ljungman, T de Witte, L Verdonck, et al.
Bone Marrow Transplantation|April 1, 1993
Randomised vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantationD C Linch, H Scarffe, S Proctor, et al.
British Journal of Cancer|July 1, 1988
In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patientsM H Bronchud, M R Potter, G Morgenstern, et al.
European Journal of Haematology|July 13, 2004
Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodiesR K Malladi, A J Peniket, A E Norton, et al.
Lancet (London, England)|May 17, 1980
The place of bone-marrow transplantation in acute myelogenous leukaemiaR L Powles, G Morgenstern, H M Clink, et al.
Lancet (London, England)|December 15, 1979
Parenteral acyclovir therapy for herpesvirus infections in manP J Selby, R L Powles, B Janeson, et al.
Lancet (London, England)|February 16, 1980
Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantationR L Powles, H M Clink, D Spence, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Blood|January 29, 2000
Molecular quantitation of minimal residual disease in acute myeloid leukemia with t(8;21) can identify patients in durable remission and predict clinical relapseK Tobal, J Newton, M Macheta, et al.
British Journal of Haematology|May 1, 1993
Bone marrow transplantation for acute myeloblastic leukaemia: an EBMT Leukaemia Working Party prospective analysis from HLA-typingP Ljungman, T de Witte, L Verdonck, et al.
Bone Marrow Transplantation|April 1, 1993
Randomised vehicle-controlled dose-finding study of glycosylated recombinant human granulocyte colony-stimulating factor after bone marrow transplantationD C Linch, H Scarffe, S Proctor, et al.
British Journal of Cancer|July 1, 1988
In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patientsM H Bronchud, M R Potter, G Morgenstern, et al.
European Journal of Haematology|July 13, 2004
Favourable outcome for patients with myeloid disorders treated with fludarabine-melphalan reduced-intensity conditioning and allogeneic bone marrow stem cell transplantation without the use of T-lymphocyte-depleting antibodiesR K Malladi, A J Peniket, A E Norton, et al.
Lancet (London, England)|May 17, 1980
The place of bone-marrow transplantation in acute myelogenous leukaemiaR L Powles, G Morgenstern, H M Clink, et al.
Lancet (London, England)|December 15, 1979
Parenteral acyclovir therapy for herpesvirus infections in manP J Selby, R L Powles, B Janeson, et al.
Lancet (London, England)|February 16, 1980
Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantationR L Powles, H M Clink, D Spence, et al.
Pageof 3